Vasopressin Levels in Spinal Fluid Linked to Aggression in People with Personality Disorders

Researchers collected cerebrospinal fluid from 26 adults meeting DSM-IV criteria for personality disorder. They measured vasopressin (AVP) and serotonin metabolite (5-HIAA) levels in the spinal fluid. Serotonin function was also assessed using a d-fenfluramine challenge test, which measures prolactin release as a proxy for central serotonin activity. Aggression was quantified using the Life History of Aggression assessment, and impulsivity was measured with the Barratt Impulsiveness Scales. Statistical correlations were then calculated between the biological markers and behavioral measures.

This study was among the first to demonstrate in humans what animal research had long suggested: that vasopressin, a peptide hormone primarily known for regulating water balance and blood pressure, also plays a role in aggressive behavior in the brain. By showing that vasopressin promotes aggression through a pathway independent of serotonin, it opened up a potential new target for managing pathological aggression in personality disorders.

This study contributed to a growing understanding that aggressive behavior is regulated by multiple neuropeptide systems, not just serotonin. The finding that vasopressin has an independent aggression-promoting effect opened a new avenue for understanding violence in psychiatric conditions and raised the possibility that vasopressin receptor antagonists could someday be explored as treatments for pathological aggression.

The sample size of 26 is very small, limiting statistical power and generalizability. The cross-sectional design cannot establish whether high vasopressin causes aggression or is a consequence of it. Only personality-disordered subjects were included, so findings may not apply to the general population. CSF sampling captures a single time point and may not reflect dynamic fluctuations in neuropeptide levels.